TABLE 3.

Staging changes from TNM7 to TNM8 for p16‐negative HNSCC patients ^a

TNM7		TNM8		Staging variation
Stage	No. of patients	Stage	No. of patients	Staging variation
III	337	III	337	No change
IVa	722	III	8	1% downstaging
		IVb	594	82% no change
		IVb 54 oral cavity 27 p16‐neg oropharynx 26 hypopharynx 13 larynx	120	17% upstaging
IVb	101	IVb	1	<1% downstaging
		IVb	100	>99% no change

^aAll tumor sites.